← Open Payments lookup

ERIC BOYUM: Open Payments

NPI 1093034266 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$472 in 21 payments from 9 companies in 2025. Trend: 2023 $731 · 2024 $998 · 2025 $472

Food & beverage: $472
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$114
Otsuka America Pharmaceutical, Inc.2$112
Janssen Pharmaceuticals, Inc3$56
Lundbeck LLC3$54
Teva Pharmaceuticals USA, Inc.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Supernus Pharmaceuticals, Inc.1$24
Alkermes, Inc.1$20
E.R. Squibb & Sons, L.L.C.1$16

Products named: INGREZZA, ABILIFY MAINTENA, INVEGA SUSTENNA, REXULTI, AUSTEDO XR, CAPLYTA, Qelbree, ARISTADA.

Industry payments across MO — which companies pay providers there.